Literature DB >> 26808137

Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD.

Timothy F Page1, William E Pelham7, Gregory A Fabiano3, Andrew R Greiner4, Elizabeth M Gnagy4, Katie C Hart4, Stefany Coxe4, James G Waxmonsky5, E Michael Foster6, William E Pelham7.   

Abstract

We conducted a cost analysis of the behavioral, pharmacological, and combined interventions employed in a sequential, multiple assignment, randomized, and adaptive trial investigating the sequencing and enhancement of treatment for children with attention deficit hyperactivity disorder (ADHD; Pelham et al., 201X; N = 146, 76% male, 80% Caucasian). The quantity of resources expended on each child's treatment was determined from records that listed the type, date, location, persons present, and duration of all services provided. The inputs considered were the amount of physician time, clinician time, paraprofessional time, teacher time, parent time, medication, and gasoline. Quantities of these inputs were converted into costs in 2013 USD using national wage estimates from the Bureau of Labor Statistics, the prices of 30-day supplies of prescription drugs from the national Express Scripts service, and mean fuel prices from the Energy Information Administration. Beginning treatment with a low-dose/intensity regimen of behavior modification (large-group parent training) was less costly for a school year of treatment ($961) than beginning treatment with a low dose of stimulant medication ($1,669), regardless of whether the initial treatment was intensified with a higher "dose" or if the other modality was added. Outcome data from the parent study (Pelham et al., 201X) found equivalent or superior outcomes for treatments beginning with low-intensity behavior modification compared to intervention beginning with medication. Combined with the present analyses, these findings suggest that initiating treatment with behavior modification rather than medication is the more cost-effective option for children with ADHD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26808137      PMCID: PMC4930413          DOI: 10.1080/15374416.2015.1055859

Source DB:  PubMed          Journal:  J Clin Child Adolesc Psychol        ISSN: 1537-4416


  24 in total

1.  Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition.

Authors:  Russell E Glasgow; Edward Lichtenstein; Alfred C Marcus
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders.

Authors:  S W Henggeler; G B Melton; L A Smith
Journal:  J Consult Clin Psychol       Date:  1992-12

3.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

4.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

5.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

6.  A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples.

Authors:  Gregory A Fabiano; William E Pelham; Daniel A Waschbusch; Elizabeth M Gnagy; Benjamin B Lahey; Andrea M Chronis; Adia N Onyango; Heidi Kipp; Andy Lopez-Williams; Lisa Burrows-Maclean
Journal:  J Clin Child Adolesc Psychol       Date:  2006-09

7.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Authors:  J M Swanson; H C Kraemer; S P Hinshaw; L E Arnold; C K Conners; H B Abikoff; W Clevenger; M Davies; G R Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; J H Newcorn; E B Owens; W E Pelham; E Schiller; J B Severe; S Simpson; B Vitiello; K Wells; T Wigal; M Wu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 8.  Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents.

Authors:  William E Pelham; Gregory A Fabiano; Greta M Massetti
Journal:  J Clin Child Adolesc Psychol       Date:  2005-09

9.  Cost-effectiveness of treatments for adolescent depression: results from TADS.

Authors:  Marisa Elena Domino; Barbara J Burns; Susan G Silva; Christopher J Kratochvil; Benedetto Vitiello; Mark A Reinecke; Jeremy Mario; John S March
Journal:  Am J Psychiatry       Date:  2008-04-15       Impact factor: 18.112

Review 10.  Empirically supported psychosocial treatments for attention deficit hyperactivity disorder.

Authors:  W E Pelham; T Wheeler; A Chronis
Journal:  J Clin Child Psychol       Date:  1998-06
View more
  18 in total

Review 1.  A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Samuele Cortese; Jeffrey H Newcorn; David Coghill
Journal:  CNS Drugs       Date:  2021-08-17       Impact factor: 5.749

2.  Effectiveness of Clinic-Based Brief Behavioral Intervention (BBI) in Long-term Reduction of ADHD Symptoms Among Preschoolers.

Authors:  Ashley E Teasdale; Petra A Duran; Marni E Axelrad
Journal:  J Clin Psychol Med Settings       Date:  2022-08-17

3.  A Cost Analysis of a Stepped Care Treatment Approach for Anxiety Disorders in Youth.

Authors:  Carlos E Yeguez; Timothy F Page; Yasmin Rey; Wendy K Silverman; Jeremy W Pettit
Journal:  J Clin Child Adolesc Psychol       Date:  2019-01-15

4.  A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD.

Authors:  William E Pelham; Lisa Burrows-MacLean; Elizabeth M Gnagy; Gregory A Fabiano; Erika K Coles; Brian T Wymbs; Anil Chacko; Kathryn S Walker; Frances Wymbs; Allison Garefino; Martin T Hoffman; James G Waxmonsky; Daniel A Waschbusch
Journal:  J Abnorm Child Psychol       Date:  2014-08

5.  Noninferiority and equivalence tests in sequential, multiple assignment, randomized trials (SMARTs).

Authors:  Palash Ghosh; Inbal Nahum-Shani; Bonnie Spring; Bibhas Chakraborty
Journal:  Psychol Methods       Date:  2019-09-09

6.  Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015.

Authors:  Rachel L Hulkower; Meghan Kelley; Lindsay K Cloud; Susanna N Visser
Journal:  Public Health Rep       Date:  2017-10-26       Impact factor: 2.792

7.  Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions.

Authors:  William E Pelham; Gregory A Fabiano; James G Waxmonsky; Andrew R Greiner; Elizabeth M Gnagy; William E Pelham; Stefany Coxe; Jessica Verley; Ira Bhatia; Katie Hart; Kathryn Karch; Evelien Konijnendijk; Katy Tresco; Inbal Nahum-Shani; Susan A Murphy
Journal:  J Clin Child Adolesc Psychol       Date:  2016-02-16

Review 8.  Adaptive Interventions in Child and Adolescent Mental Health.

Authors:  Daniel Almirall; Andrea Chronis-Tuscano
Journal:  J Clin Child Adolesc Psychol       Date:  2016-06-16

Review 9.  Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.

Authors:  Arthur Caye; James M Swanson; David Coghill; Luis Augusto Rohde
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

10.  Treatment Patterns and Costs Among Children Aged 2 to 17 Years With ADHD in New York State Medicaid in 2013.

Authors:  Liqiong Guo; Melissa Danielson; Lindsay Cogan; Leah Hines; Brian Armour
Journal:  J Atten Disord       Date:  2018-12-14       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.